CIK 0000874015 · Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 330336973
- Phone
- 7609319200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-15 | Swayze Eric EVP Research | Option exercise | +111 | 367 | ||
| 2026-01-15 | Swayze Eric EVP Research | Grant or award · Performance Restricted Stock Units | +25,800 | 90,282 | ||
| 2026-01-15 | Swayze Eric EVP Research | Option exercise · Restricted Stock Unit | −21,366 | 39,251 | ||
| 2026-01-15 | Swayze Eric EVP Research | Grant or award · Restricted Stock Unit | +9,675 | 48,926 | ||
| 2026-01-15 | Swayze Eric EVP Research | Option exercise · Restricted Stock Unit | −111 | 386 | ||
| 2026-01-15 | Swayze Eric EVP Research | Grant or award · Restricted Stock Unit | +225 | 611 | ||
| 2026-01-15 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Option exercise | +21,685 | 73,192 | ||
| 2026-01-15 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Grant or award · Performance Restricted Stock Units | +25,800 | 91,237 | ||
| 2026-01-15 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Option exercise · Restricted Stock Unit | −21,685 | 39,251 | ||
| 2026-01-15 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Grant or award · Restricted Stock Unit | +9,675 | 48,926 | ||
| 2026-01-15 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise | +21,473 | 75,362 | ||
| 2026-01-15 | O'NEIL PATRICK R. EVP CLO & General Counsel | Grant or award · Performance Restricted Stock Units | +25,800 | 90,601 | ||
| 2026-01-15 | O'NEIL PATRICK R. EVP CLO & General Counsel | Option exercise · Restricted Stock Unit | −21,473 | 39,251 | ||
| 2026-01-15 | O'NEIL PATRICK R. EVP CLO & General Counsel | Grant or award · Restricted Stock Unit | +9,675 | 48,926 | ||
| 2026-01-15 | Monia Brett P Chief Executive Officer | Option exercise | +89,145 | 268,717 | ||
| 2026-01-15 | Monia Brett P Chief Executive Officer | Grant or award · Performance Restricted Stock Units | +113,880 | 744,081 | ||
| 2026-01-15 | Monia Brett P Chief Executive Officer | Option exercise · Restricted Stock Unit | −89,145 | 163,014 | ||
| 2026-01-15 | Monia Brett P Chief Executive Officer | Grant or award · Restricted Stock Unit | +42,705 | 205,719 | ||
| 2026-01-15 | Kordasiewicz Holly B. EVP, Chief Development Officer | Option exercise | +11,119 | 18,859 | ||
| 2026-01-15 | Kordasiewicz Holly B. EVP, Chief Development Officer | Option exercise · Restricted Stock Unit | −11,119 | 20,830 |
Page 14 of 18 · 360 trades